MedTrace Logo

Evaluation of Clinical Decision Support System-mPDia for Neurodegenerative Parkinsonism Using MRI Images

NCT04334902 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 221

Last updated 2025-10-29

Study results available
· View outcomes & findings →

Summary

mPDia is a software that has been pre-learned based on a neurodegenerative parkinsonism diagnosis model using Nigrosome 1 MRI images, and clinical decision support system for diagnosing neurodegenerative parkinsonism by automatically analyzing Nigrosome 1 MRI images by assisting the medical team.

The specific aims of this study are to evaluate efficacy of mPDia for neurodegenerative Parkinsonism compared to the sensitivity and specificity levels of 18F FP-CIT PET/CT which is currently used to diagnose neurodegenerative parkinsonism.

Conditions

  • Diagnoses Disease

Interventions

DEVICE

mPDia

Clinical decision support system for diagnosing neurodegenerative parkinsonism

Sponsors & Collaborators

  • Heuron Inc.

    lead INDUSTRY

Principal Investigators

  • YoungHee Sung, M.D, Ph.D · Gachon University Gil Medical Center

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-13
Primary Completion
2020-06-24
Completion
2020-10-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04334902 on ClinicalTrials.gov